Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP
Clinical trial NCT02049866 · COMPLETED
Trial details
- NCT number
- NCT02049866
- Sponsor
- Elizabeth Shane
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-19
- Primary completion
- 2020-03-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.